Strive 1000 Growth ETF (STXG)
Live price chart, market sentiment, and community perspectives for Strive 1000 Growth ETF (NYSE: STXG).
Live price chart, market sentiment, and community perspectives for Strive 1000 Growth ETF (NYSE: STXG).
On our trading desk, we've been tracking the recent Q2 2026 filings for STXG. Seeing 47 hedge funds and large institutions hold $83.5M—with new positions and net capital additions lifting overall institutional ownership to 56.08%—gives us great confidence in the long-term accumulation trend of this vehicle, even if near-term price movement is sluggish.
From a risk management standpoint, the technical setup on STXG indicates neutral near-term readings. Resistance is actively being tested near current price levels. If these levels hold, our models flag a potential short setup targeting roughly 4.5% downside versus 0.3% risk, meaning we need to watch tight stop-loss boundaries closely.
Looking at the market sentiment data, the aggregate Wall Street analyst rating sits at a Moderate Buy with a score of 2.84. However, despite a strong 1-year performance trailing near 19.52%, the 1-year fund flows show a negative reading of -$6.23M, telling an interesting story of asset outflows happening concurrently with underlying equity appreciation.
When evaluating passive index products for long-term allocation, STXG's expense ratio of 0.18% stands out as highly cost-efficient. Tracking the Bloomberg US 1000 Growth index with an 8% annual turnover rate provides a tax-efficient profile for clients wanting large- and mid-cap exposure coupled with Strive's active corporate governance strategy.
As a portfolio analyst reviewing STXG's fundamental metrics, the NAV is sitting around $56.00 with a minimal premium/discount spread hovering near -0.02% to 0.2%. The median 30-day bid-ask spread remains tight at 0.09%, reflecting healthy liquidity and execution conditions for a fund with roughly $151 million to $153.9 million in total assets.
When structuring our quantitative risk models around STXG, we incorporate the fund's lack of listed options liquidity into our liquidation protocols. Since options data is limited, risk mitigation must rely strictly on equity stop-loss triggers and monitoring the median bid-ask spreads rather than utilizing complex derivative hedging structures.
Explore plasma cleansing, somatic organ swaps, and BCI.